Search studies
4 studies found
204869 Phase 2a/b in Ulcerative Colitis
ELU-4-907C53-1
204869 Phase 2a/b in Ulcerative Colitis
AMCUC study
ELU-4-54A576-1
AMCUC study
LUCENT-1 (NCT 03518086)
ELU-4-58F581-1
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Pfizer (NCT02958865)
ELU-4-B16B4B-1
The Pfizer UC dataset represents baseline, placebo and treatment (PF-06700841) subject and sample-level data extracted from a phase 2 study in moderate to severe ulcerative colitis.